Pyrroloquinoline Quinone Attenuates Traumatic Brain Injury‐Induced Secondary Damage by Activating PINK1/Parkin‐Mediated Mitophagy and Suppressing ASS1/CPS1‐Driven Arginine Biosynthesis
CNS Neuroscience & Therapeutics · 2026-09 · 32 (9)
DOI: 10.1002/cns.71146 ↗Kurz gefasst
Fachartikel in der Zeitschrift CNS Neuroscience & Therapeutics, online erschienen am 09.09.2026. Verfasst von Yanan He und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology, The First Medical Center of Chinese PLA General Hospital, Beijing, China. Hauptthemen laut MEDLINE: Brain Injuries, Traumatic, PQQ Cofactor, Ubiquitin-Protein Ligases, Arginine. Die Arbeit nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Aims
Pyrroloquinoline quinone (PQQ) was reported to be neuroprotective after experimental traumatic brain injury (TBI), but its mechanisms remain undefined. We tested whether PQQ protects against TBI in mice and identified the associated pathways.
Methods
Male C57BL/6 mice received intraperitoneal PQQ (6.25, 12.5 or 25 mg/kg) immediately after controlled cortical impact. Mortality, modified neurological severity score (mNSS) and beam balance were followed to day 14; histopathology, immunofluorescence, western blot, ELISA and ATP assays were performed on day 3. Transcriptomics, metabolomics, network pharmacology and docking were integrated to identify candidate mechanisms.
Results
PQQ reduced mortality (lowest at 12.5 mg/kg) and dose‐dependently improved neurological deficits, neuronal apoptosis, brain edema, pro‐inflammatory cytokines, and oxidative stress; the mNSS and beam balance benefits persisted to day 14. At 12.5 mg/kg, multi‐omics and network pharmacology identified arginine biosynthesis, mediated by argininosuccinate synthetase 1 (ASS1) and carbamoyl phosphate synthetase 1 (CPS1), as the top‐ranked pathway suppressed by PQQ; docking predicted binding of PQQ to both enzymes, suggesting putative targets pending validation. PQQ concurrently restored PTEN‐induced kinase 1 (PINK1)/Parkin‐mediated mitophagy and ATP production.
Conclusion
PQQ attenuates secondary injury after TBI in male mice, in association with increased markers of PINK1/Parkin‐mediated mitophagy initiation and suppressed ASS1/CPS1‐driven arginine biosynthesis, identifying a candidate dual‐axis mechanism and nominating the mitophagy‐arginine axis as a target for neuroprotection in TBI.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Anesthesiology, The First Medical Center of Chinese PLA General Hospital, Beijing, China.
- Beijing Key Laboratory of Perioperative Multimodal Digital Intelligence-Integrated Diagnosis and Treatment, Beijing, China.
- Department of Pharmacology, School of Basic Medical Sciences, State Key Laboratory of Medical Neurobiology, Fudan University, Shanghai, China.
ORCID-Profile: Yanan He, Yixun Lu, Lu Wang, Zhili Huang, Yanhong Liu, Yulong Ma, Weidong Mi
Zitieren
APA
He, Y., Yu, L., Lu, Y., Zhou, Z., Li, A., Wang, L., Huang, Z., Liu, Y., Ma, Y., & Mi, W. (2026). Pyrroloquinoline Quinone Attenuates Traumatic Brain Injury‐Induced Secondary Damage by Activating PINK1/Parkin‐Mediated Mitophagy and Suppressing ASS1/CPS1‐Driven Arginine Biosynthesis. CNS Neuroscience & Therapeutics, 32(9). https://doi.org/10.1002/cns.71146
Vancouver
He Y, Yu L, Lu Y, Zhou Z, Li A, Wang L, et al. Pyrroloquinoline Quinone Attenuates Traumatic Brain Injury‐Induced Secondary Damage by Activating PINK1/Parkin‐Mediated Mitophagy and Suppressing ASS1/CPS1‐Driven Arginine Biosynthesis. CNS Neuroscience & Therapeutics. 2026;32(9). doi:10.1002/cns.71146
BibTeX
@article{He2026,
author = {He, Yanan and Yu, Lu and Lu, Yixun and Zhou, Zhikang and Li, Ao and Wang, Lu and Huang, Zhili and Liu, Yanhong and Ma, Yulong and Mi, Weidong},
title = {Pyrroloquinoline Quinone Attenuates Traumatic Brain Injury‐Induced Secondary Damage by Activating PINK1/Parkin‐Mediated Mitophagy and Suppressing ASS1/CPS1‐Driven Arginine Biosynthesis},
journal = {CNS Neuroscience & Therapeutics},
year = {2026},
volume = {32},
number = {9},
doi = {10.1002/cns.71146}
}
EUVIMED